SR

Sumantra Ray

Active Director Director DIN 09163456
DIN 09163456 First appointment Apr 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Sumantra Ray

Data last updated:

Sumantra Ray is a Director at Indo Asia International Hospital Private Limited (since 2021). The company operates in Healthcare.

DIN 09163456
Primary Designation Director
Industry Healthcare
First Appointment 30 Apr 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Apr 20212021Active

Directorship timeline

Open interactive timeline →
Indo Asia International Hospital Private Limited
Premium access

Shareholding and investment profile for Sumantra Ray

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sumantra Ray

Sumantra Ray currently holds 1 directorship: Indo Asia International Hospital Private Limited (Director, since 30 Apr 2021).

Sumantra Ray was first appointed on 30 Apr 2021 as Director at Indo Asia International Hospital Private Limited.

The current boards of Sumantra Ray's companies include Dwaipayan Jha (Indo Asia International Hospital Private Limited), Mohammed Sharique Sayeed (Indo Asia International Hospital Private Limited), Rina Barman (Indo Asia International Hospital Private Limited), Sunilbaran Daschakraborty (Indo Asia International Hospital Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available